Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (1986)	2/9/2002 11:32:55 PM
From: Cacaito	Read Replies (1) of 2515

Biotechs will be in tougher situation to negotiate, they will be trusted less, they will be scrutinized more, small biotechs will be the losers, venture capital will be more expensive so more control for the venture guys (who already have much of it)than the scientists. Big Pharma will benefit cause they will claim the Bmy/imcl factor in their negotiations. Bmy already figured out their best way out, they will not invest a single cent more on Erbitux, they will sell imcl stock, they will used the Imcl cash to their advantage, and they will reap the profits of Erbitux in the lucky case that the "potential" turns out to work. Imcl insiders already got the money in their pockets, unless the SEC/FBI deliver the alleged culprits, they will enjoy their profits. Biotechs are the losers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next